Alpha 1-antichymotrypsin may be a biomarker for the progression of amnestic mild cognitive impairment

Overview of attention for article published in Acta Neurologica Belgica, September 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 11 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Alpha 1-antichymotrypsin may be a biomarker for the progression of amnestic mild cognitive impairment.

Alzforum, 13 Sep 2019

. Alpha 1-antichymotrypsin may be a biomarker for the progression of amnestic mild cognitive impairment.